Data / Form D filings / MEDRACON, INC.
MEDRACON, INC.: Form D filing
MEDRACON, INC., a pharmaceuticals company in Oak Brook, IL, filed a Form D with the SEC in 2009. The latest, on October 8, 2009, reports an offering of $6 million with nothing sold yet.
Find out what MEDRACON, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1415 WEST 22ND STREET, TOWER FLOOR, Oak Brook, IL, 60523
- Phone
- (630) 858-4000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Illinois
- Year incorporated
- 2009
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1473377
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2009 | New notice | $6,000,000 | $0 | $6,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edward L Ma | Executive Officer, Director | |
| Min L Li | Director | |
| Frank L Jaksch | Executive Officer, Director | |
| Arlene L Corris Coles | Executive Officer | |
| Eric L Coles | Executive Officer | |
| Thomas L Varvaro | Director |
Every Form D from the week of Oct 5, 2009 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MEDRACON, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.